LP
RGEN icon

Longaeva Partners’s Repligen RGEN Stock Holding History

Longaeva Partners’s Portfolio RGEN Stock Details RGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.36M Buy
+24,616
New +$3.02M 0.07% 217

Other funds holding RGEN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
UCFA
United Capital Financial Advisors Irving, Texas $18.2B AUM 22.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
MC
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Longaeva Partners's RGEN Position: Q2 2026 in Review

Longaeva Partners opened a new position in Repligen (RGEN) in Q2 2026: 24,616 shares worth $3.36M. The stake represents 0.07% of the portfolio and ranks #217 among its holdings.

477 funds tracked by Wall St. Rank hold RGEN as of Q2 2026.

  • Longaeva Partners held 24,616 shares of Repligen worth $3.36M as of Q2 2026.
  • Repligen was a new Longaeva Partners position in Q2 2026.
  • Repligen made up 0.07% of Longaeva Partners's portfolio in Q2 2026, its #217 holding.
  • 477 funds tracked by Wall St. Rank held Repligen as of Q2 2026.

Based on Longaeva Partners's 13F filing for Q2 2026, filed 14 Aug 2026.